Detalles de la búsqueda
1.
The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research.
Eur J Clin Pharmacol
; 77(4): 557-568, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188452
2.
The Safety, Toleration, and Pharmacokinetics of Two Intravenous Voriconazole Formulations in Healthy Chinese Volunteers After Increasing Dose Administrations.
Clin Pharmacol Drug Dev
; 11(10): 1211-1220, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711147
3.
Application of a Cloud Video Conference Method for Recruiting Healthy Subjects Into an Early-Phase Clinical Trial During the COVID-19 Pandemic.
Front Public Health
; 9: 657804, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34490177
4.
Pharmacokinetics, Safety, and Bioequivalence of Two Empagliflozin Formulations after Single Oral Administration under Fasting and Fed Conditions in Healthy Chinese Subjects: An Open-label Randomized Single-dose Two-sequence, Two-treatment, Two-period Crossover Study.
Pharmacotherapy
; 40(7): 623-631, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498113
5.
A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers.
Front Pharmacol
; 10: 905, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474863
6.
Bioequivalence study of single-dose lenalidomide capsule vs. Revlimid® capsule in healthy Chinese males.
Cancer Chemother Pharmacol
; 82(1): 159-164, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29926217
7.
How to safely and smoothly resume trials after the COVID-19 outbreak.
J Glob Health
; 10(2): 020310, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33110514
Resultados
1 -
7
de 7
1
Próxima >
>>